Technology

Dr Nissen discusses the impetus behind the study, the potential public health implications of the results, and more.

The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.

Your daily dose of the clinical news you may have missed.

Cologuard Plus bests previous iteration and demonstrates greater sensitivity and specificity for any CRC relative to fecal immunochemical tests.

Findings from the ECLIPSE clinical trial showed the blood-based cancer screening test detects 83% of people with CRC, with a specificity of 90%.

A CPT code for time spent petitioning insurance companies to approve patient prescriptions has been proposed before; sentiment was not unanimous.

One study showed a significant 1.5% decrease in HbA1c 6 months after participants taking a GLP-1 RA started using the Freestyle Libre system.

The Dexcom system is for adults over the age of 18 years who do not use insulin, such as individuals with T2D who use oral medications, a US population of 25 million.

The digital prescription therapeutic when used along with prescription diabetes therapies, can help reduce the costs of managing the disease and enhance standard of care.

Beware the potential pitfalls of telemedicine, from privacy concerns to patient confusion, says associate general counsel for The Doctors Company.

Nearly 90% of patients are more likely to choose a doctor who incorporates wearable data into their health care plans, according to a new report.

Telehealth use is waning consistently from its peak use during the pandemic, raising the question of what the future holds for virtual care.

Your daily dose of clinical news you may have missed.

New research shows that patients with heart failure who had more steps per day and increasing steps per day experienced better health status over 12 weeks.

The device from Nexalin Technology outperformed placebo on key measures of pain relief, sleep quality, anxiety, and quality of life.

Physiatrist DJ Kennedy, MD, is excited by the potential for new, and even existing technology, to present novel options for diagnosis, monitoring, and treatment.

AspyreRx™, prescribed in 90-day increments, resulted in a mean HbA1c reduction of 1.3% at 180 days in 1 out of 2 phase 3 trial participants. A Q4 launch is anticipated.

The certification is available to all health care professionals and aims to standardize training and increase skills in telehealth care delivery and integration into practice.

Your daily dose of clinical news you may have missed.

Try this 7-question quiz on the 2023 guidelines from The Endocrine Society that focus on advances in diabetes treatment that help minimize risk of hypoglycemia.

Mean time in range increased by ~10% and time above range decreased by 8.1% in study participants taking as few as a single antihyperglycemic medication.

Prescriptions for continuous glucose monitoring for patients with T2D are increasing, a new study finds, and the authors report on characteristics of new CGM users.

Your daily dose of clinical news you may have missed.

Findings from new study demonstrate the potential benefits of continuing telehealth services and medications for opioid use disorder.

Your daily dose of clinical news you may have missed.

An Apple Watch feature designed to detect atrial fibrillation was associated with a low rate of false-positive detections and high specificity in persons with AF.

Your daily dose of clinical news you may have missed.

ACC 2023. Electronic nudges highlighting the potential cardiovascular benefits of flu vaccination led to a modest uptake in vaccination rates among older adults in Denmark, according to results of the NUDGE-FLU trial.

The prescription remote electrical neuromodulation device is now cleared for both acute and preventive treatment of migraine in those aged ≥12 years, according to Theranica.

ACC 2023. New study found cognitive behavioral therapy delivered via mobile app significantly reduced HbA1c and need for antihyperglycemic intensification compared to use of a control app.